Similar Search Results

Health policy, price regulation, and innovation : evidence from China's vaccine industry

Geng, Hao; Shi, Ce Matthew - In: Journal of development economics 167 (2024), pp. 1-22

Persistent link: https://www.econbiz.de/10014454554

Impacts of population aging on the quantity and quality of pharmaceutical innovation : evidence from OECD countries

Shen, Ke; Huang, Zhenyi - In: China economic journal : the official journal of the … 16 (2023) 3, pp. 335-353

Persistent link: https://www.econbiz.de/10014369677

Public health insurance and pharmaceutical innovation : evidence from China

Zhang, Xuan; Nie, Huihua - In: Journal of development economics 148 (2021), pp. 1-27

Persistent link: https://www.econbiz.de/10012658986

Unpacking the effects of adverse regulatory events : Evidence from pharmaceutical relabeling

Higgins, Matthew J.; Yan, Xin; Chatterjee, Chirantan - In: Research policy : policy, management and economic … 50 (2021) 1, pp. 1-15

Persistent link: https://www.econbiz.de/10012663313

Methodology for constructing scenarios for health policy research : the case of coverage decision-making for drugs for rare diseases in Canada

Douglas, Conor M. W.; Panagiotoglou, Dimitra; … - In: Technological forecasting & social change : an … 171 (2021), pp. 1-14

Persistent link: https://www.econbiz.de/10012807204

Partnership and innovation in the pharmaceutical industry : the case of clinical research

Ippoliti, R.; Ramello, Giovanni B.; Scherer, Frederic M. - In: Economics of innovation and new technology 30 (2021) 3, pp. 317-334

Persistent link: https://www.econbiz.de/10012498349

The Structural Genomics Consortium : successful organisational technology experiment or new institutional infrastructure for health research?

Jones, Molly Morgan; Chataway, Joanna - In: Technology analysis & strategic management 33 (2021) 3, pp. 296-306

Persistent link: https://www.econbiz.de/10012501341

Pharmaceutical M&A activity : effects on prices, innovation, and competition

Richman, Barak; Mitchell, Will; Vidal, Elena; Schulman, … - 2017

The rise of blockbuster pharmaceutical acquisitions has prompted fears that unprecedented market concentration will weaken competition. Two of the most prominent concerns focus on the upstream and downstream ends of the pharmaceutical industry: (1) the concern that these mergers will concentrate...

Persistent link: https://www.econbiz.de/10011721586

Public subsidies for R&D and public sector pharmaceutical innovation

Kourouklis, Dimitrios - In: Applied economics 53 (2021) 32, pp. 3759-3777

Persistent link: https://www.econbiz.de/10012589537

Pharmaceutical markets in Japan and the United States

Comanor, William S. - In: International journal of economic policy studies 16 (2022) 2, pp. 355-370

Persistent link: https://www.econbiz.de/10013433326